Concept and mechanism
Evidence-Based Management offers complementary perspectives for discussing improvement. Current Value examines value delivered today; Unrealized Value helps investigate unmet needs. Time-to-Market directs attention to the ability to respond and deliver, while Ability-to-Innovate helps examine conditions enabling new capabilities. High release frequency does not automatically establish satisfaction or sustainable capability. If regressions consume almost all time, an organization may deliver quickly while struggling to evolve. Use these perspectives to ask concrete questions rather than adding incompatible indicators into a score hiding trade-offs.
Guided application
Choose measures related to goals and context. The guide appendix contains examples, not a universally mandatory set. Budget, activity, and delivered features may explain investment and execution but do not themselves demonstrate a changed experience. Also examine segments: rising average satisfaction may coexist with more failures in a critical group. A large backlog does not directly measure Unrealized Value; each item may represent an unevaluated hypothesis. Define boundaries, data provenance, and limitations. If an experiment improves internal flow, monitor user effects and future capability before claiming overall success. The aim is better decisions using evidence clear enough to be challenged and revised.
Four monthly releases, stable satisfaction, and 45% of capacity spent on regressions require combined interpretation; frequency alone does not answer everything.
Common pitfalls
Appendix metrics as requirements; backlog as guaranteed value; average as every segment; speed as overall health.
Related topics: Portfolio, investment, and the product operating model · Accountability and product direction
Measure to learn about value and capability while retaining visible context and limits.
Reference: The Evidence-Based Management Guide · PSPO II; Scrum Guide November 2020 and EBM Guide May 2024; no public numbered exam revision